share_log

Apyx Medical Corporation Prelim. Q4 Revenue $12.1M-$12.5M Vs $13.35M Est., Sees Prelim. FY22 Revenue $44M-$44.4M Vs $45.2M Est.

Benzinga Real-time News ·  Jan 10, 2023 07:07
Apyx Medical Corporation Prelim. Q4 Revenue $12.1M-$12.5M vs $13.35M Est., Sees Prelim. FY22 Revenue $44M-$44.4M vs $45.2M Est.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment